SE0402976D0 - A medical product - Google Patents

A medical product

Info

Publication number: SE0402976D0
Authority: SE; Sweden
Prior art keywords: medical product; container; dose; optionally; inhalation
Prior art date: 2004-12-03

Application number

SE0402976A

Other languages

English (en)

Other versions

SE0402976L (sv

Inventor

Thomas Nilsson

Sven Calander

Alf Niemi

Claes Friberg

Lars Kax

Mattias Myrman

Original Assignee

Microdrug Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-03

Filing date

2004-12-03

Publication date

2004-12-03

2004-12-03 Application filed by Microdrug Ag filed Critical Microdrug Ag

2004-12-03 Priority to SE0402976A priority Critical patent/SE0402976L/sv

2004-12-03 Publication of SE0402976D0 publication Critical patent/SE0402976D0/sv

2005-02-04 Priority to US11/049,696 priority patent/US20060120969A1/en

2005-11-02 Priority to EP05801482A priority patent/EP1827381A1/en

2005-11-02 Priority to AU2005310367A priority patent/AU2005310367A1/en

2005-11-02 Priority to JP2007544302A priority patent/JP2008521893A/ja

2005-11-02 Priority to ZA200705376A priority patent/ZA200705376B/xx

2005-11-02 Priority to CNA2005800476483A priority patent/CN101111226A/zh

2005-11-02 Priority to CA002589118A priority patent/CA2589118A1/en

2005-11-02 Priority to KR1020077015300A priority patent/KR20070095927A/ko

2005-11-02 Priority to BRPI0518600-5A priority patent/BRPI0518600A2/pt

2005-11-02 Priority to PCT/SE2005/001648 priority patent/WO2006059939A1/en

2005-11-02 Priority to RU2007124795/15A priority patent/RU2007124795A/ru

2005-11-02 Priority to MX2007006533A priority patent/MX2007006533A/es

2005-11-15 Priority to US11/272,859 priority patent/US20060239933A1/en

2006-06-04 Publication of SE0402976L publication Critical patent/SE0402976L/sv

2007-06-03 Priority to IL183623A priority patent/IL183623A0/en

Links

229940127554 medical product Drugs 0.000 title abstract 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
102100025101 GATA-type zinc finger protein 1 Human genes 0.000 abstract 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000004888 barrier function Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940112141 dry powder inhaler Drugs 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
210000004072 lung Anatomy 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Packages (AREA)
Peptides Or Proteins (AREA)

SE0402976A 2004-12-03 2004-12-03 Medicinsk produkt SE0402976L (sv)

Priority Applications (15)

Application Number	Priority Date	Filing Date	Title
SE0402976A SE0402976L (sv)	2004-12-03	2004-12-03	Medicinsk produkt
US11/049,696 US20060120969A1 (en)	2004-12-03	2005-02-04	Medical product for inhalation containing glucagon-like peptide-1 (GLP-1)
MX2007006533A MX2007006533A (es)	2004-12-03	2005-11-02	Un producto medico que comprende un medicamento peptidico tipo glucagon pretendido para inhalacion pulmonar.
CNA2005800476483A CN101111226A (zh)	2004-12-03	2005-11-02	包含预期用于肺吸入的胰高血糖素样肽药物的医学产品
BRPI0518600-5A BRPI0518600A2 (pt)	2004-12-03	2005-11-02	produto mÉdico compreendendo um medicamento de peptÍdeo tipo glucagon, idealizado para inalaÇço pulmonar
JP2007544302A JP2008521893A (ja)	2004-12-03	2005-11-02	肺吸入用のグルカゴン様ペプチド薬物を含む医療品
ZA200705376A ZA200705376B (en)	2004-12-03	2005-11-02	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
EP05801482A EP1827381A1 (en)	2004-12-03	2005-11-02	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
CA002589118A CA2589118A1 (en)	2004-12-03	2005-11-02	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
KR1020077015300A KR20070095927A (ko)	2004-12-03	2005-11-02	폐 흡입을 위한 글루카곤-형 펩타이드 약제를 포함하는의약품
AU2005310367A AU2005310367A1 (en)	2004-12-03	2005-11-02	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
PCT/SE2005/001648 WO2006059939A1 (en)	2004-12-03	2005-11-02	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
RU2007124795/15A RU2007124795A (ru)	2004-12-03	2005-11-02	Медицинский продукт, содержащий лекарственное средство на основе глюкагоноподобного пептида, предназначенное для легочной ингаляции
US11/272,859 US20060239933A1 (en)	2004-12-03	2005-11-15	Medical product
IL183623A IL183623A0 (en)	2004-12-03	2007-06-03	A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0402976A SE0402976L (sv)	2004-12-03	2004-12-03	Medicinsk produkt

Publications (2)

Publication Number	Publication Date
SE0402976D0 true SE0402976D0 (sv)	2004-12-03
SE0402976L SE0402976L (sv)	2006-06-04

Family

ID=33550603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0402976A SE0402976L (sv)	2004-12-03	2004-12-03	Medicinsk produkt

Country Status (9)

Country	Link
US (2)	US20060120969A1 (sv)
JP (1)	JP2008521893A (sv)
CN (1)	CN101111226A (sv)
BR (1)	BRPI0518600A2 (sv)
IL (1)	IL183623A0 (sv)
MX (1)	MX2007006533A (sv)
RU (1)	RU2007124795A (sv)
SE (1)	SE0402976L (sv)
ZA (1)	ZA200705376B (sv)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
EP1808438B1 (en)	1999-06-29	2014-10-01	MannKind Corporation	Purification and stabilization of peptide and proteins in pharmaceutical agents
ES2425392T3 (es)	2002-03-20	2013-10-15	Mannkind Corporation	Cartucho para un aparato de inhalación
US20080260838A1 (en) *	2003-08-01	2008-10-23	Mannkind Corporation	Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
US8921311B2 (en)	2003-08-01	2014-12-30	Mannkind Corporation	Method for treating hyperglycemia
DK1786784T3 (da)	2004-08-20	2011-02-14	Mannkind Corp	Katalyse af diketopiperazinsyntese
BR122019022692B1 (pt)	2004-08-23	2023-01-10	Mannkind Corporation	Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
SE0402976L (sv) *	2004-12-03	2006-06-04	Mederio Ag	Medicinsk produkt
WO2007033372A2 (en)	2005-09-14	2007-03-22	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US20130172274A1 (en)	2005-12-20	2013-07-04	Duke University	Methods and compositions for delivering active agents with enhanced pharmacological properties
DK1986679T3 (da)	2006-02-22	2017-11-20	Mannkind Corp	Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
DE102006031962A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Amidiertes Insulin Glargin
KR20100090692A (ko) *	2007-10-24	2010-08-16	맨카인드 코포레이션	활성제의 전달
HUE025485T2 (en) *	2007-10-24	2016-02-29	Mannkind Corp	Respiratory dry powder formulation containing GLP-1 for use in the treatment of hyperglycemia and diabetes by pulmonary administration
US8785396B2 (en)	2007-10-24	2014-07-22	Mannkind Corporation	Method and composition for treating migraines
CA3153292A1 (en)	2008-06-13	2009-12-17	Mannkind Corporation	A dry powder inhaler and system for drug delivery
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
CN102065942B (zh)	2008-06-20	2013-12-11	曼金德公司	用于对吸入工作进行实时描绘的交互式设备和方法
WO2009158704A2 (en)	2008-06-27	2009-12-30	Duke University	Therapeutic agents comprising elastin-like peptides
TWI532497B (zh)	2008-08-11	2016-05-11	曼凱公司	超快起作用胰島素之用途
HUE048608T2 (hu)	2008-10-17	2020-08-28	Sanofi Aventis Deutschland	Egy inzulin és egy GLP-1 agonista kombinációja
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
DK2379100T3 (en)	2009-01-08	2014-12-01	Mannkind Corp	Treatment of hyperglycemia with GLP-1
ES2739352T3 (es)	2009-02-26	2020-01-30	Glaxo Group Ltd	Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
PL2405963T3 (pl)	2009-03-11	2014-04-30	Mannkind Corp	Urządzenie, układ i sposób pomiaru oporu inhalatora
KR20180036807A (ko)	2009-06-12	2018-04-09	맨카인드 코포레이션	한정된 비표면적을 갖는 디케토피페라진 마이크로입자
JP5801997B2 (ja) *	2009-07-07	2015-10-28	ファイザー・リミテッドＰｆｉｚｅｒＬｉｍｉｔｅｄ	薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器
EP2482840A4 (en)	2009-08-07	2013-06-26	Mannkind Corp	VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME
CA2778698A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
RU2537239C2 (ru)	2009-11-13	2014-12-27	Санофи-Авентис Дойчланд Гмбх	Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
LT2498801T (lt)	2009-11-13	2018-05-10	Sanofi-Aventis Deutschland Gmbh	Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
US20110118178A1 (en) *	2009-11-13	2011-05-19	Sanofi-Aventis Deutschland Gmbh	Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
WO2011121425A1 (en) *	2010-03-31	2011-10-06	Glenmark Pharmaceuticals Limited	Pharmaceutical powder composition for inhalation
RU2571331C1 (ru)	2010-06-21	2015-12-20	Маннкайнд Корпорейшн	Системы и способы доставки сухих порошковых лекарств
HUE031181T2 (en)	2010-08-30	2017-06-28	Sanofi Aventis Deutschland	Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
KR101940832B1 (ko)	2011-04-01	2019-01-21	맨카인드 코포레이션	의약 카트리지용 블리스터 패키지
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
RU2650616C2 (ru)	2011-08-29	2018-04-16	Санофи-Авентис Дойчланд Гмбх	Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2776053A1 (en)	2011-10-24	2014-09-17	MannKind Corporation	Methods and compositions for treating pain
CN104619369B (zh)	2012-07-12	2018-01-30	曼金德公司	干粉药物输送系统和方法
EP2911690A1 (en)	2012-10-26	2015-09-02	MannKind Corporation	Inhalable influenza vaccine compositions and methods
AU2014228415B2 (en)	2013-03-15	2018-08-09	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
CA2918369C (en)	2013-07-18	2021-06-29	Mannkind Corporation	Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en)	2013-08-05	2015-02-12	Mannkind Corporation	Insufflation apparatus and methods
US20150038674A1 (en) *	2013-08-05	2015-02-05	Bayrak Bertan Boran	Use of glp-2 analogues in pulmonary diseases for therapeutic purpose
US10307464B2 (en) *	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
FI3229828T3 (fi)	2014-12-12	2023-05-29	Sanofi Aventis Deutschland	Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
JP2019504671A (ja)	2016-01-11	2019-02-21	サイケメディカルリミテッドＳｙｑｅＭｅｄｉｃａｌＬｔｄ．	個人用気化デバイス
WO2023224577A1 (en) *	2022-05-18	2023-11-23	Arven Ilac Sanayi Ve Ticaret Anonim Sirketi	Inhalation compositions comprising micronized human insulin
CN115192554A (zh) *	2022-08-08	2022-10-18	浙江仙琚萃泽医药科技有限公司	无抛射剂的含肽吸入溶液剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9409496D0 (en) *	1994-05-12	1994-06-29	London Health Ass	Method for improving glycaemic control in diabetes
US6720407B1 (en) *	1998-08-28	2004-04-13	Eli Lilly And Company	Method for administering insulinotropic peptides
FI108518B (sv) *	1999-04-23	2002-02-15	Orion Yhtymae Oyj	Pulverinhalator för kombinationsmedicin
US6528486B1 (en) *	1999-07-12	2003-03-04	Zealand Pharma A/S	Peptide agonists of GLP-1 activity
US20010012829A1 (en) *	2000-01-11	2001-08-09	Keith Anderson	Transepithelial delivery GLP-1 derivatives
US7186683B2 (en) *	2000-09-18	2007-03-06	Sanos Bioscience A/S	Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
SE518397C2 (sv) *	2001-04-05	2002-10-01	Microdrug Ag	Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver
SE524990C2 (sv) *	2002-04-12	2004-11-09	Microdrug Ag	Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE0402976L (sv) *	2004-12-03	2006-06-04	Mederio Ag	Medicinsk produkt

2004
- 2004-12-03 SE SE0402976A patent/SE0402976L/sv not_active Application Discontinuation
2005
- 2005-02-04 US US11/049,696 patent/US20060120969A1/en not_active Abandoned
- 2005-11-02 CN CNA2005800476483A patent/CN101111226A/zh active Pending
- 2005-11-02 MX MX2007006533A patent/MX2007006533A/es unknown
- 2005-11-02 BR BRPI0518600-5A patent/BRPI0518600A2/pt not_active Application Discontinuation
- 2005-11-02 RU RU2007124795/15A patent/RU2007124795A/ru not_active Application Discontinuation
- 2005-11-02 ZA ZA200705376A patent/ZA200705376B/xx unknown
- 2005-11-02 JP JP2007544302A patent/JP2008521893A/ja active Pending
- 2005-11-15 US US11/272,859 patent/US20060239933A1/en not_active Abandoned
2007
- 2007-06-03 IL IL183623A patent/IL183623A0/en unknown

Also Published As

Publication number	Publication date
US20060239933A1 (en)	2006-10-26
US20060120969A1 (en)	2006-06-08
JP2008521893A (ja)	2008-06-26
IL183623A0 (en)	2007-09-20
BRPI0518600A2 (pt)	2008-11-25
SE0402976L (sv)	2006-06-04
RU2007124795A (ru)	2009-01-10
ZA200705376B (en)	2008-12-31
MX2007006533A (es)	2007-08-02
CN101111226A (zh)	2008-01-23

Publication	Publication Date	Title
SE0402976D0 (sv)	2004-12-03	A medical product
BRPI0417155A (pt)	2007-03-06	produto medicinal compreendendo tiotrópio em um recipiente à prova de umidade
MY187036A (en)	2021-08-27	Inhalation device and method
MX2010008234A (es)	2010-08-10	Nueva dosificacion y formulacion.
WO2012041938A3 (en)	2012-06-14	Inhaler
CY1110636T1 (el)	2015-04-29	Προ-δοσιμετρημενος εισπνευστηρας ξηρης σκονης για φαρμακα ευαισθητα στην υγρασια
CY1110625T1 (el)	2015-04-29	Μεθοδος για την χορηγηση τιοτροπιου
MX2010008235A (es)	2010-08-10	Nueva dosificacion y formulacion.
Rave et al.	2004	Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles 1
SE0401612D0 (sv)	2004-06-18	Inhaler using pods
JP2004533438A5 (sv)	2005-06-30
Skyler	2005	Pulmonary insulin update

Legal Events

Date	Code	Title	Description
2006-11-28	NAV	Patent application has lapsed
2006-12-12	NAV	Patent application has lapsed

SE0402976D0 - A medical product - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (15)

Applications Claiming Priority (1)

Publications (2)

Family

ID=33550603

Family Applications (1)

Country Status (9)

Families Citing this family (56)

Family Cites Families (9)

Also Published As

Similar Documents

Legal Events